The problem with potency

被引:20
作者
Scott, CT
机构
关键词
D O I
10.1038/nbt0905-1037
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Industry hopes to build on recent successes of monoclonal antibodies in oncology and inflammatory disease. But evidence is mounting that the exquisite selectivity and binding capacity of these therapeutics can have unwanted side effects, particularly in autoimmune disease. Christopher Thomas Scott investigates.
引用
收藏
页码:1037 / 1039
页数:3
相关论文
共 6 条
[1]   Progressive multifocal leukoencephalopathy and natalizumab - Unforeseen consequences [J].
Berger, JR ;
Koralnik, IJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :414-416
[2]   Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy [J].
Özcelik, C ;
Erdmann, B ;
Pilz, B ;
Wettschureck, N ;
Britsch, S ;
Hübner, N ;
Chien, KR ;
Birchmeier, C ;
Garratt, AN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8880-8885
[3]   Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma [J].
Phan, GQ ;
Yang, JC ;
Sherry, RM ;
Hwu, P ;
Topalian, SL ;
Schwartzentruber, DJ ;
Restifo, NP ;
Haworth, LR ;
Seipp, CA ;
Freezer, LJ ;
Morton, KE ;
Mavroukakis, SA ;
Duray, PH ;
Steinberg, SM ;
Allison, JP ;
Davis, TA ;
Rosenberg, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8372-8377
[4]   Third Tysabri adverse case hits drug class [J].
Sheridan, C .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (05) :357-358
[5]   Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab [J].
Steinman, L .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) :510-U3
[6]   PREVENTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ANTIBODIES AGAINST ALPHA-4-BETA-1 INTEGRIN [J].
YEDNOCK, TA ;
CANNON, C ;
FRITZ, LC ;
SANCHEZMADRID, F ;
STEINMAN, L ;
KARIN, N .
NATURE, 1992, 356 (6364) :63-66